Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia

J.A. Gomez-Gerique; E. Ros; J. Olivan; J.M. Mostaza; M. Vilardell; X. Pinto; F. Civeira; A. Hernandez; P.M. da Silva; A. Rodriguez-Botaro; D. Zambon; J. Lima; C. Diaz; et al.

Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia

J.A. Gomez-Gerique, E. Ros, J. Olivan, J.M. Mostaza, M. Vilardell, X. Pinto, F. Civeira, A. Hernandez, P.M. da Silva, A. Rodriguez-Botaro, D. Zambon, J. Lima, C. Diaz, et al.

Departament de Medicina

Producció científica: Contribució a revista › Article › Recerca

48 Cites (Scopus)

Idioma original	Anglès
Pàgines (de-a)	245-251
Revista	Atherosclerosis
Volum	162
Número	6
Estat de la publicació	Publicada - 1 de juny 2002

Altres arxius i enllaços

https://www.scopus.com/pages/publications/0036242297

Com citar-ho

@article{2dc7bad77ff04052befe7a418dbeab94,

title = "Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia",

author = "J.A. Gomez-Gerique and E. Ros and J. Olivan and J.M. Mostaza and M. Vilardell and X. Pinto and F. Civeira and A. Hernandez and \{da Silva\}, P.M. and A. Rodriguez-Botaro and D. Zambon and J. Lima and C. Diaz and \{et al.\}",

year = "2002",

month = jun,

day = "1",

language = "English",

volume = "162",

pages = "245--251",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

number = "6",

}

TY - JOUR

T1 - Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia

AU - Gomez-Gerique, J.A.

AU - Ros, E.

AU - Olivan, J.

AU - Mostaza, J.M.

AU - Vilardell, M.

AU - Pinto, X.

AU - Civeira, F.

AU - Hernandez, A.

AU - da Silva, P.M.

AU - Rodriguez-Botaro, A.

AU - Zambon, D.

AU - Lima, J.

AU - Diaz, C.

AU - et al.,

PY - 2002/6/1

Y1 - 2002/6/1

UR - https://www.scopus.com/pages/publications/0036242297

M3 - Article

SN - 0021-9150

VL - 162

SP - 245

EP - 251

JO - Atherosclerosis

JF - Atherosclerosis

IS - 6

ER -